Company Team
Co-Founder & President
Mr. Lei Chen
- 20+ yrs of operating management experience and resource integration ability in pharmaceutical enterprises
- Former Executive Vice president/Director of Hunan Jinsha Pharmaceutical Co., LTD., and led the listing of Jinsha Pharmaceutical
- Shareholders and directors of multiple proposed listed companies
Co-Founder & CEO
Dr. Sean Li
- 30+ yrs experience in peptide chemistry and biology
- 10 yrs CRO experience in peptide technology and services. Former Exec. Director of Peptide Technology and Services in WuXi AppTec
- Ph.D. in Chemistry from Peking University; Postdoc at Purdue, University of Maryland and Osaka University
Co-Founder & Senior Vice President
Mr. Huanzhang Gong
- 20+ yrs of experience in pharmaceutical enterprise operation and management
- Former General Manager of Hunan Jinsha Pharmaceutical Trading Company;Sales Manager of Zhuhai Tianda Pharmaceutical
- Has invested in Jinsha Pharmaceutical, Anxin Biological, Huateng Pharmaceutical, Yuanxu Optoelectronics and other companies (financial investment)
Vice President
Mr.Xinbo Wang
- Former R&D Director of Chengdu Shengnuo
- Former Director of Peptide Technology and Service Department at WuXi AppTec
- Former R&D manager of Kingsrui Peptide Department
Senior Vice President Drug Discovery
Dr. Henry Liu
- 25+ yrs of industrial research and management experience in drug screening, pharmacology from early discovery to preclinical late stage
- Former Director of Neurorscience in Chempartner; V.P. of Biology in PharmaCore Labs; Scientist at Icagen Inc. & Neuromed
- M.D. in Clinical Medicine/Cardiac Surgery from Peking University
Executive Director, R&D Strategy
Dr. Wenge Liu
- 20+ yrs of industrial and academic research experience in DMPK, drug delivery life cycle management
- Former V.P. of Hainan R&D Center at Simcere Pharma; Senior Director of DPMK at Senior Director of DMPK Suzhou Wuxi AppTech; Research Professor, Biomedical Engineering, Duke University
- M.D. in Medicine from Tianjin Medical University and Ph.D. in Pharmaceutical Sciences from Kumamoto University
Executive Director, In Vitro Biology
Dr. Shiu-Feng Tung
- 20+ yrs of industrial and academic research experience in high throughput screening, assay development and receptor pharmacology
- Former Senior Dzirector of R&D at Tripartite Therapeutics; Supervisor of Taipai Facility at Arena Pharmaceuticals; Director of High Throughput Screening and Receptor Pharmacology at TaiGen Biotechnology; Principal Investigator of GPCR Project at Development Center for Biotechnology
- Ph.D. in Life Science from Institute of Life Science, Academia Sinica/National Health Research Institute/National Defense Medical Center Joint Program
Deputy General Advisor, R&D Strategy
Dr. Qiuyun Dai
- a Ph.D. degree in Beijing Institute of Pharmaceutical Chemistry, worked as a postdoctoral fellow in Beijing Institute of Biotechnology and in the Department of Chemistry and Biochemistry at the University of Notre Dame
- Former vice president of Discovery Chemistry of Shanghai ChemPartner, the director, principal investigator (professor) and doctoral supervisor of the Peptide Chemistry Laboratory of the Academy of Military Medical Sciences
- Completed a number of clinical or preclinical studies of Class I innovative drugs, and is familiar with peptide and small molecule drug design, synthesis (including large-scale manufacture), quality study, pharmacology and drug application process
Vice President, R&D Strategy
Dr. Yantao He
- He is a highly experienced peptide medicinal chemist with over 20 years of expertise in academia and the pharmaceutical industry
- He has served as Senior Director of Peptide Chemistry at GeneScience Pharmaceuticals and played key roles in drug discovery at Neurocrine Biosciences, Novo Nordisk Research Center Indianapolis (NNRCI), and Indiana University School of Medicine
- He holds a Ph.D. from Shanghai Institute of Organic Chemistry, Chinese Academy of Sciences
Senior Director, Executive Director
Dr. Yilong Li
- 10+ years of peptide drug development experience, team leading experience from target/indication selection to PCC/IND
- Former Senzior Principal Scientist at Jiangsu Hengrui Medicine Co.,Senior Scientist at Creative Peptides, Development Scientist PolyPeptide Group
- Ph.D. in Pharmaceutical Sciences at USC
PepLib aims to promote the development and accessibility of innovative peptide drugs, benefiting global patients and human health while keeping costs low.
Copyright©2023 Zonsen PepLib Biotech Inc. This website supports IPV6
Business License